MarketInOut Stock Screener Log In | Sign Up

NeoGenomics Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/30/2026
NeoGenomics Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,217.74 mln
Float127 mln
Earnings Date02/23/2027

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.35
Borderline

1-Year Forecast

23.33
Strong upside

Relative Strength

84 / 100
Strongly outperforming

Debt / Equity

0.56
Moderate leverage

Pre-Tax Margin

-5%
Marginally loss-making

Business Description

NeoGenomics is a specialized cancer testing company with laboratories across the United States and United Kingdom. It serves a wide range of clients, including hospitals, oncologists, and pharmaceutical companies, providing them with detailed analysis of cancer cells, genes, and tissue samples. This work helps doctors make accurate diagnoses and supports drug companies in developing and bringing new cancer treatments to market. Founded in 2001 and based in Fort Myers, Florida, the company plays an important role in advancing cancer care.

Key Fundamentals

EPS-0.24
ROE-3.95
RPS6.11
ROIC-3.54
ROA-2.37
Interest Cover-14.51
EBITDA, mln32.27
EV / EBITDA77.60
EV / EBIT-76.04
Revenue, mln788
EV / Revenue3.18

Quote Details

Last 17.38
Change -0.55 (-3.07%)
Open 17.95
Volume 1,463,309
Turnover 25,432,310
Average Volume 2,181,591

Financial Ratios

Pre-Tax Profit Margin-5
Leverage Ratio1.72
Current Ratio3.53
Price / Book2.77
Price / Tangible Book172
Price / Cash Flow515
Debt / Equity0.56
Price / Sales2.81
PEG Ratio2.09

Financial Strength

Altman Z-Score2.68
Piotroski F-Score 5 / 9
Beneish M-Score-2.35
Price to Intrinsic Value20.42
1-Year Target Price23.33
Short Ratio5.78
Short % of Float12.98

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.76% 88 / 100   
1 Month -2.25% 47 / 100   
2 Months 32.27% 95 / 100   
6 Months 84.11% 98 / 100   
1 Year 69.07% 95 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog